Identification and Validation of a Threshold for Early Posttransplant Bronchoalveolar Fluid Hyaluronan that Distinguishes Lung Recipients at Risk for CLAD

By sjmartinez • October 25, 2024

Todd JL, Weber JM, Kelly FL, Nagler A, McArthur P, Eason L, Rim JG, Frankel CW, Belperio JA, Budev M, Martinu T, Patel K, Reynolds JM, Shah PD, Singer LG, Snyder LD, Tsuang W, Weigt SS, Neely ML, Palmer SM. Identification and Validation of a Threshold for Early Posttransplant Bronchoalveolar Fluid Hyaluronan that Distinguishes Lung Recipients at Risk for CLAD. J Heart Lung Transplant. 2024 Oct 22:S1053-2498(24)01900-4. doi: 10.1016/j.healun.2024.10.014. Epub ahead of print. PMID: 39448000.

Tags: bronchoalveolar lavage fluid, chronic lung allograft dysfunction, hyaluronan, Lung transplantation, Publications, Pulmonary, Critical Care & Sleep Medicine

A pilot-test to support healthcare providers in promoting vaccine uptake among individuals with intellectual and developmental disabilities

Hotez E, Rava J, Khorasani L, Levenson AP, Shen T, Chen L, Klomhaus AM, Kuo AA. A pilot-test to support healthcare providers in promoting vaccine[...]

Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells

Wu K, Ge XX, Duan XF, Li JQ, Wang K, Chen QH, Huang ZM, Zhang WY, Wu Y, Li Q. Wip1 phosphatase activator QGC-8-52 specifically[...]

The Association between the Social Vulnerability Index and Access to California High School Athletic Trainers

Tao F, Turner C, Kliethermes S, Luke A, Berrigan W, Hatamiya N. The Association between the Social Vulnerability Index and Access to California High School[...]